Breast Cancer Trial, Not Yet Recruiting NCT07671937 Sponsor: University of Alabama at Birmingham Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Not Yet Recruiting

NCT07671937
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged 18 years or older.
  • People with a suspected or confirmed diagnosis of pancreatic, breast, or gynecologic cancer (any stage) within 8 weeks of receiving that diagnosis.
  • People who plan to be treated at one of the participating hospitals or clinics.
  • People who speak English or Spanish fluently.
  • People whose case is scheduled to be discussed at a Multidisciplinary Tumor Board (a meeting where a team of specialists reviews a patient's case together).
  • Clinical team members who are part of the pancreatic, breast, or gynecologic Multidisciplinary Tumor Board at a participating site and have already agreed in advance to take part.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who plan to receive their cancer treatment at a hospital or clinic that is not part of the trial.
  • People who are not able to speak English or Spanish.
  • Individual clinicians may choose to opt out of participation, in which case their contributions to the discussion will not be included in the study data (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Gabrielle B Rocque, MD, The University of Alabama at Birmingham

Phone: (205) 975-2914

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 September 2026
Est. completion
1 July 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Treatment modifications

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov